List of top English Language Comprehension Questions

Read the given passage and answer the question that follows:
Biological classification of plants and animals was first proposed by Aristotle on the basis of simple morphological characters. Linnaeus later classified all living organisms into two kingdoms- Plantae and Animalia. Whittaker proposed an claborate five kingdom classification- Monera, Protista, Fungi, Plantae and Animalia. The main criteria of the five kingdom classification were cell structure, body organisation, mode of nutrition and reproduction. and phylogenetic relationships. 
In the five kingdom classification. bacteria are included in Kingdom Monera. Bacteria are cosmopolitan in distribution. These organisms show the most extensive metabolic diversity. Bacteria may be autotrophic or heterotrophic in their mode of nutrition. Kingdom Protista includes all single-celled eukaryotes such as Chrysophytes. Dinoflagellates. Euglenoids. Slime-moulds and Protozoans. Protists have defined nucleus and other membrane bound organelles. They reproduce both asexually and sexually. Members of Kingdom Fungi show a great diversity in structures and habitat. Most Fungi are saprophytic in their mode of nutrition. They show asexual and sexual reproduction. Phycomycetes. Ascomycetes. Basidiomycetes and Deuteromycetes are the four classes under this kingdom. The plantae includes all eukaryotic chlorophyll-containing organisms. Algae. bryophytes. pteridophytes. gymnosperms and angiosperms are included in this group. The life cycle of plants exhibit alternation of generations- gametophytic and sporophytic generations. The heterotrophic eukaryotic, multicellular organisms lacking a cell wall are included in the kingdom Animalia. The mode of nutrition of these organisms is holozoic. They reproduce mostly by the sexual mode. Some acellular organisms like viruses and viroids as well as the lichens are not included in the five kingdom system of classification.
Read the given passage and answer the questions that follow:
Drug major Novartis is planning to divest its Indian eyecare portfolio to Mumbaibased JB Chemicals, in a deal estimated to be around ¥ 1.000 crore. The Novartis spin-off will join the list of several MNCs pruning their drug portfolios and reducing exposure to the Indian market, due to multiple reasons. including increased competition and tough business environment. Sources say the move fits well with the MNC’s strategy to capitalize its ophthalmic therapy, while for JB Chemicals it will offer an entry into a growing business segment.
Over last few months, global Big Pharma have been divesting their branded generic portfolio to domestic companies and rationalizing their portfolio by selling off key assets. Further, large Indian players are doubling down on India as an attractive diversification from a USgenerics market beaten up heavily by price erosion. As a consequence, several deals were inked where Indian companies snapped up high-growth brands from MNCs and local sellers at attractive valuations. The deal is expected to be announced over the next few days. Emails sent across to Novartis and JB Chemicals did not elicit a response. Ageing population and increasing access to eyecare. especially in emerging markets, is a strong growth opportunity for drug companies. The demand for eyecare is expected to increase significantly as people spend more time in front of tablets and mobile devices. Sources added that existing eyecare portfolio in India of Novartis is understood to be around Z 400-500 crore. including certain brands transferred from eyecare biggie Alcon. when it was spun off from Novartis. In 2019 under a global restructuring move, Novartis had spun off Alcon into a standalone business to focus on its core area of pharmaceuticals. Alcon is a global leader in eyecare, offering solutions to issues like cataracts, glaucoma., retinal diseases and refractive errors. 
The stock market seems to have got a wind of the potential deal. Over the last few days. scrips of both Novartis India and JB Chem have witnessed a spurt. On December 7, JB Chem traded on a new 52-week high at Z 1555, while Novartis India stock closed Z 706 on Friday. Further. Novartis had last year announced the transfer of sales & distribution of a few of its established medicines, including the Voveran and Calcium range to Dr.Reddy’s.